Results 21 to 30 of about 289,605 (341)
miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2
Technology in Cancer Research & Treatment, 2020 Purpose: Triple-negative breast cancer is characterized by fast progression with high possible for metastasis and poor survival. Dysfunction of microRNAs plays an important role in the initiation and progression of cancer.
Mingchuan Zhao PhD +5 more
doaj +1 more source
Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
Pharmaceutics, 2023 Triple negative breast cancer (TNBC) has a negative expression of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptors (HER2).
O. Obidiro, G. Battogtokh, E. Akala
semanticscholar +1 more source
Technology in Cancer Research & Treatment, 2020 Background: Triple-negative breast cancer encompasses heterogeneous subtypes. Neoadjuvant chemotherapy is ineffective against some triple-negative breast cancers, while others show a favorable prognosis despite chemoresistance.
Koichi Kubouchi MD +3 more
doaj +1 more source
MicroRNAs expression in triple negative vs non triple negative breast cancer in Tunisia: interaction with clinical outcome. [PDF]
PLoS ONE, 2014 MicroRNAs are small, non coding regulatory molecules containing approximately 21 to 25 nucleotides. They function as controllers of expression at post transcriptional levels of most human protein-coding genes and play an essential role in cell signaling ...
Imen Medimegh +10 more
doaj +1 more source
Advances in immunotherapy for triple-negative breast cancer
Molecular Cancer, 2023 Background Immunotherapy has recently emerged as a treatment strategy which stimulates the human immune system to kill tumor cells. Tumor immunotherapy is based on immune editing, which enhances the antigenicity of tumor cells and increases the ...
Yang Liu +8 more
semanticscholar +1 more source
Treatment of thrice-negative breast cancer in a patient with metabolic syndrome
Исследования и практика в медицине, 2021 Breast cancer (BC) remains one of the most common diseases of the female population. According to statistics, breast cancer is detected in every eighth woman. Approximately 20‑24% of breast cancer patients are diagnosed with triple negative breast cancer.
G. E. Roitberg +2 more
doaj +1 more source
Recent advances in targeted strategies for triple-negative breast cancer
Journal of Hematology & Oncology, 2023 Triple-negative breast cancer (TNBC), a highly aggressive subtype of breast cancer, negatively expresses estrogen receptor, progesterone receptor, and the human epidermal growth factor receptor 2 (HER2).
Shuangli Zhu +6 more
semanticscholar +1 more source
Technology in Cancer Research & Treatment, 2021 Triple-negative breast cancer is a heterogeneous disease with different molecular and histological subtypes. The Androgen receptor is expressed in a portion of triple-negative breast cancer cases and the activation of the androgen receptor pathway is ...
Taobo Hu +3 more
doaj +1 more source
Pathogenesis of Triple-Negative Breast Cancer.
Annual Review of Pathology, 2022 Triple-negative breast cancer (TNBC) encompasses a heterogeneous group of fundamentally different diseases with different histologic, genomic, and immunologic profiles, which are aggregated under this term because of their lack of estrogen receptor ...
F. Derakhshan, J. Reis-Filho
semanticscholar +1 more source
Frontiers in Oncology, 2023 Triple-negative breast cancer refers to breast cancer patients with negative estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER2).
Ruoyan Qin +6 more
doaj +1 more source